Mycobacterium attenuatum
DSM 107153
Name:
Mycobacterium attenuatum Tagini et al. 2019
DSM No.:
107153, Type strain dsm-107153 dsm107153 dsm 107153 Mycobacterium attenuatum
Strain designation:
MK41
Isolated from:
Bronchial aspiration (Human)
Country:
Switzerland
Lausanne
Lausanne
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- F. Tagini, Lausanne University Hospital; MK41
Genbank accession numbers:
Cultivation conditions:
Summary and
additional information:
additional information:
<- F. Tagini, Lausanne University Hospital; MK41. Bronchial aspiration (Human). Switzerland, Lausanne. Type strain.. Taxonomy/description (33727, 38082). Sequence accession no. 16S rRNA gene: LS999934, complete genome shotgun sequence: GCA_900566085. (Medium 645, incubation time: 7-14 days, pH 7, 37°C, aerobic)
Risk group:
2 (provisional classification by DSMZ)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
Supplied as:
Delivery form | Prices | ||
Freeze Dried | 100,- € | ||
Active culture on request | 240,- € | ||
DNA | 150,- € | ||
Price Category for this culture: 1 |
Freight and handling charges will be added. See price list.
Note: Freight charges for Risk Group 2 microorganisms will apply.
Other cultures: